Polyestriol phosphate
Polyestriol phosphate (PE3P, SEP), sold under the brand names Gynäsan, Klimadurin, and Triodurin, is an estrogen medication which was previously used in menopausal hormone therapy (i.e., to treat menopausal symptoms in postmenopausal women) and is no longer available.
Skeletal structure of polyestriol phosphate (top) and ball-and-stick model of estriol phosphate (one monomer of polyestriol phosphate) (bottom) | |
Clinical data | |
---|---|
Trade names | Gynäsan, Klimadurin, Triodurin |
Other names | PE3P; SEP; Poly(estriol phosphate); Estriol phosphate polymer; Estriol polymer with phosphoric acid |
Routes of administration | Intramuscular injection |
Drug class | Estrogen; Estrogen ester |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | IM: High |
Metabolites | Estriol, phosphoric acid, and metabolites of estriol |
Excretion | Urine (as conjugates) |
Identifiers | |
| |
CAS Number | |
UNII | |
Chemical and physical data | |
Formula | (C18H23O5P)n (n = variable) |
Molar mass | Polymer: Variable Repeat unit: 350.346 g/mol |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.